Cluster Headache

Galcanezumab Effective in Phase 3 Episodic Cluster Headache Study

Galcanezumab Effective in Phase 3 Episodic Cluster Headache Study

By

The episodic cluster headache trial included a total of 106 patients with an average of 17.5 cluster headache attacks per week at baseline.

New Device for Treating Cluster Headaches Available

New Device for Treating Cluster Headaches Available

gammaCore, a hand-held device for treating episodic cluster headaches via mild electrical stimulation of the vagus nerve is now available in the United States.

Vagal Stimulation Device Gets FDA Approval for Cluster Headaches

Vagal Stimulation Device Gets FDA Approval for Cluster Headaches

By

The FDA has approved the use of gammaCore, the first handheld, non-invasive device to treat pain associated with episodic cluster headaches in adults.

Management of Sleep Disorders-Related Headaches

Management of Sleep Disorders-Related Headaches

Headaches are a common complaint in primary care, and they are often connected to sleep in a variety of ways.

Sign Up for Free e-Newsletters